Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02420340 · ClinicalTrials.gov registry record · NA

Using The HOPES Program in Transition Care

A NA study of Serious Mental Illness and Psychosocial Rehabilitation, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT02420340: Completed NA study of Serious Mental Illness and Psychosocial Rehabilitation, sponsored by Dartmouth-Hitchcock Medical Center.

NCT02420340 is a NA study of Serious Mental Illness and Psychosocial Rehabilitation that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 12 participants, below the 139-participant average among 7 other Serious Mental Illness trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02420340, a NA study of Serious Mental Illness and Psychosocial Rehabilitation, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This pilot study will collect information about the the potential to use an evidence-based skills training program designed for older people with serious mental illness (SMI), the Helping Older People Experience Success (HOPES) program, to help nursing home residents with SMI gain the skills needed to successfully live in the community.

Primary Outcome

attendance records

Interventions

  • BEHAVIORAL HOPES Program ("Helping Older People Experience Success")

Study Locations (1)

New Hampshire

  • Glencliff Home - Glencliff

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2014-09
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT02420340 record still lists

NCT02420340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 139-participant average among 7 other Serious Mental Illness trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Serious Mental Illness appearing as the primary indexed condition, and to 1 intervention - of which HOPES Program ("Helping Older People Experience Success") is the first listed.

NCT02420340 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT02420340 about?

NCT02420340 is a clinical study titled "Using The HOPES Program in Transition Care". This pilot study will collect information about the the potential to use an evidence-based skills training program designed for older people with serious mental illness (SMI), the Helping Older People Experience Success (HOPES) program, to help nursing home residents with SMI gain the skills needed ...

What is the current status of trial NCT02420340?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-09.

What conditions does trial NCT02420340 study?

This clinical trial studies the following conditions: Serious Mental Illness, Psychosocial Rehabilitation.

What interventions are being tested in trial NCT02420340?

The interventions under investigation include: HOPES Program ("Helping Older People Experience Success") (BEHAVIORAL).

Who is sponsoring clinical trial NCT02420340?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02420340 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Serious Mental Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02420340, the US trial registry maintained by the National Library of Medicine. NCT02420340 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.